Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析

◆英語タイトル:Neuren Pharmaceuticals Ltd (NEU) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14855
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is suitable for intravenous infusion and oral delivery. Neuren Pharma undertakes clincal trials for several drugs. The company’s trofinetide is a clinical stage drug candidate it provides molecule which is derived from IGF-1 and occurs naturally in the brain. Its drugs are also used in neurodevelopmental disorders such as angelman syndrome and idiopathic autism, or neurodegenerative disorders such as Parkinson’s disease and multiple sclerosis. Neuren Pharma is headquartered in Camberwell, Victoria, Australia.

Neuren Pharmaceuticals Ltd Key Recent Developments

Feb 27,2019: Neuren Pharmaceuticals: Preliminary final report for the financial year ended 31 December 2018
Dec 18,2018: Neuren Pharmaceuticals: 2018 year-end business update
Dec 17,2018: Larry Glass to retire as a director and continue as chief science officer
Oct 31,2018: Neuren Pharmaceuticals: Appendix 4C report for the quarter ended 30 September 2018
Sep 22,2018: FDA reaffirms positive benefit-risk of ACADIA”s NUPLAZID

This comprehensive SWOT profile of Neuren Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Neuren Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Neuren Pharmaceuticals Ltd – Key Information
Neuren Pharmaceuticals Ltd – Overview
Neuren Pharmaceuticals Ltd – Key Employees
Neuren Pharmaceuticals Ltd – Key Employee Biographies
Neuren Pharmaceuticals Ltd – Key Operational Heads
Neuren Pharmaceuticals Ltd – Major Products and Services
Neuren Pharmaceuticals Ltd – History
Neuren Pharmaceuticals Ltd – Company Statement
Neuren Pharmaceuticals Ltd – Locations And Subsidiaries
Neuren Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Neuren Pharmaceuticals Ltd – Business Description
Neuren Pharmaceuticals Ltd – Corporate Strategy
Neuren Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Neuren Pharmaceuticals Ltd – Strengths
Neuren Pharmaceuticals Ltd – Weaknesses
Neuren Pharmaceuticals Ltd – Opportunities
Neuren Pharmaceuticals Ltd – Threats
Neuren Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Neuren Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Neuren Pharmaceuticals Ltd, Key Information
Neuren Pharmaceuticals Ltd, Key Ratios
Neuren Pharmaceuticals Ltd, Share Data
Neuren Pharmaceuticals Ltd, Major Products and Services
Neuren Pharmaceuticals Ltd, History
Neuren Pharmaceuticals Ltd, Key Employees
Neuren Pharmaceuticals Ltd, Key Employee Biographies
Neuren Pharmaceuticals Ltd, Key Operational Heads
Neuren Pharmaceuticals Ltd, Other Locations
Neuren Pharmaceuticals Ltd, Subsidiaries
Neuren Pharmaceuticals Ltd, Key Manufacturing facilities
Neuren Pharmaceuticals Ltd, Key Competitors
Neuren Pharmaceuticals Ltd, SWOT Analysis
Neuren Pharmaceuticals Ltd, Ratios based on current share price
Neuren Pharmaceuticals Ltd, Annual Ratios
Neuren Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Neuren Pharmaceuticals Ltd, Performance Chart
Neuren Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Community Trust Bancorp Inc:企業の戦略・SWOT・財務情報
    Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Societe Tunisienne de l’Electricite et du Gaz:企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Avery Dennison Corporation (AVY)-医療機器分野:企業M&A・提携分析
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, radio-frequency identific …
  • AMC Airlines:企業の戦略・SWOT・財務情報
    AMC Airlines - Strategy, SWOT and Corporate Finance Report Summary AMC Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hikma Pharmaceuticals PLC:戦略・SWOT・企業財務分析
    Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Engro Corp Ltd (ENGRO):企業の財務・戦略的SWOT分析
    Engro Corp Ltd (ENGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • HemaCare Corp (HEMA)-医療機器分野:企業M&A・提携分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood. It spans its expertise in isolations, custom cell collections and testing of pr …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務分析
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Elsalys Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Probiodrug AG (PBD):製薬・医療:M&Aディール及び事業提携情報
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Norwest Venture Partners XII, LP:企業のM&A・事業提携・投資動向
    Norwest Venture Partners XII, LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwest Venture Partners XII, LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Guess?, Inc.:戦略・SWOT・企業財務分析
    Guess?, Inc. - Strategy, SWOT and Corporate Finance Report Summary Guess?, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務情報
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EZCORP Inc (EZPW):企業の財務・戦略的SWOT分析
    EZCORP Inc (EZPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆